Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature

Bornstein, Michael; Oberli, Kaspar; Stauffer, Edouard; Buser, Daniel (2006). Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature. Schweizerische Monatsschrift für Zahnmedizin, 116(10), pp. 1035-47. Bern: Schweizerische Zahnärzte-Gesellschaft

	Text smfz-10-praxis2.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (187kB) | Request a copy
	Text f-smfz-10-praxis2.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (75kB) | Request a copy

In recent years, a growing number of reports in the literature have linked osteonecrosis of the jaw bones with intravenously administered bisphosphonates prescribed for the treatment of hypercalcemia of malignancy due to bone lesions of multiple myeloma or bone metastases in patients with breast or prostate cancer. Furthermore, an association between chronic oral bisphosphonate use in patients with osteoporosis or Paget's disease, and bone necrosis in the mandible or maxilla has been demonstrated in numerous case reports and case series in the last couple of years. Therapeutically, osteonecrosis of the jaws seems to be difficult to treat surgically, often resulting in a recurring or even progressing lesion. In the present case report of a bisphosphonate-associated osteonecrosis of the maxilla in a patient with osteoporosis, the current literature will be discussed, and open research questions and potential problems for our daily dental practice routine will be addressed.

Interest & Impact

Downloads

1096 since deposited on 04 Oct 2013
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item